UNSPSC 51282311: Clarithromycin lactobionate

This classification denotes a macrolide antibiotic C38H69NO13.C12H22O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4108JKI097, chemically known as erythromycin, 6-o-methyl-, 4-o-.beta.-d-galactopyranosyl-d-gluconate (1:1), but more generally known as clarithromycin lactobionate, which bears US NIH Compound Identifier 178265. European Medicines Agency schedules Clarithromycin lactobionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20333.

Most nations, for tariff and trade purposes, schedule clarithromycin lactobionate under HS 29415000 and SITC 54139. SMILES: As of Q4 2014, CLARITHROMYCIN LACTOBIONATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51282311 Clarithromycin lactobionate is a Commodity code that nominally names a single antibiotic product, yet recent state and local opportunities tagged under it show little activity aligned with that specific pharmaceutical. The recent opportunities record one medical and first aid supplies solicitation from the City of Tampa Fire Department Rescue Division (IFB 26P00145, due March 13, 2026, estimated contract value $700,000.00) that encompasses 169 line items of emergency response and medical consumables including respiratory equipment, electrodes, endotracheal tubes, gloves, and bandaging materials — a broad class of supplies unrelated to clarithromycin lactobionate specifically. The remaining three opportunities — Seminole County's naloxone and drug deactivation systems procurement (IFB60459723LAS, due July 26, 2023), the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions (HHS0017013, April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's generic multi-source pharmaceuticals RFP (S1070000015802, due March 26, 2026) — concern pharmaceutical programs, procurement mechanisms, and supply chain arrangements that do not track to a single active pharmaceutical ingredient. The code shows limited relevance to the opportunities actually being posted.

Geographic activity centers on Florida (Seminole County), Texas (state HHS), Minnesota (multistate cooperative), and Tennessee (City of Tampa), reflecting dispersed state and local health procurement rather than concentrated demand. Issuing bodies include county government (Seminole County), city fire/rescue departments (Tampa), state health agencies (Texas HHS), and cooperative purchasing alliances serving multiple jurisdictions (MMCAP). The mismatch between the code's nominal scope — a specific antibiotic preparation — and the actual work being solicited suggests that this Commodity code captures limited recent activity directly aligned with clarithromycin lactobionate procurement. Business development professionals should verify whether opportunities appearing under this code reflect systematic purchasing of the named product or represent tagging errors before allocating pursuit resources.